Bioplan: Software for the biological evaluation of radiotherapy treatment plans

Medical Dosimetry

Volumn 25, Issue 2, 2000, Pages 71-76

  Sanchez Nieto, B ^a   Nahum, A E ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Biological evaluation; DVH; NTCP; Radiotherapy; TCP

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; COMPUTER ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER PROGRAM; HISTOGRAM; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION RESPONSE; STATISTICAL ANALYSIS;

HUMANS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SOFTWARE;

EID: 0034036868     PISSN: 09583947     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-3947(00)00031-5     Document Type: Article

References (23)

1. Nahum A.E., Tait D. Maximising local control by customised dose prescription for pelvic tumours. Breit A. Advanced radiation therapy tumour response monitoring and treatment planning. 1992;425-431 Springer-Verlag, Heidelberg.
2. Webb S., Nahum A.E. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys. Med. Biol. 38:1993;653-666.
3. Niemierko A., Goitein M. Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. Radiother. Oncol. 29:1993;140-147.
4. Lyman J.T. Complication probabilities as assessed from dose-volume histograms. Radiat. Res. 104:1985;S13-S19.
5. Kutcher G.J., Burman C. Calculation of complication probability factors for non uniform normal tissue irradiation the effective volume method. Int. J. Radiat. Oncol. Biol. Phys. 16:1989;1623-1630.
6. Niemierko A., Goitein M. Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture. Radiat. Oncol. 20:1991;166-176.
7. Niemierko A., Goitein M. Modeling of normal tissue response to radiation the critical volume model. Int. J. Radiat. Oncol. Biol. Phys. 25:1993;135-145.
8. Källman P., Ågren A., Brahme A. Tumour and normal tissue responses to fractionated non-uniform dose delivery. Int. J. Radiat. Biol. 62:1992;249-262.
9. Niemierko A., Urie M., Goitein M. Optimization of 3D radiation therapy with both physical and biological end points and constraints. Int. J. Radiat. Oncol. Biol. Phys. 23:1992;99-108.
10. Sanchez-Nieto B., Nahum A.E. The delta-TCP method a clinical useful measure of tumour control probability. Int. J. Radiat. Oncol. Biol. Phys. 44:1999;369-380.
11. Niemierko A. Reporting and analysing dose distributions a concept of equivalent uniform dose. Med. Phys. 24:1997;103-110.
12. Fowler J.F. The linear quadratic formula and progress in fractionated radiotherapy. Br. J. Radiol. 62:1989;679-694.
13. Fowler J.F., Ritter M.A. A rationale for fractionation for slowly proliferating tumors such as prostatic adenocarcinoma. Int. J. Radiat. Oncol. Biol. Phys. 32:1995;521-529.
14. Haustermans K.M.G., Hofland I., van Poppel H., et al. Cell kinetic measurements in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;1067-1070.
15. Burman C., Kutcher G.J., Emami B., et al. Fitting of normal tissue tolerance data to an analytic function. Int. J. Radiat. Oncol. Biol. Phys. 21:1991;123-135.
16. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 21:1991;109-122.
17. Withers H.R., Taylor J.M.G., Maciejewiski B. Treatment volume and tissue tolerance. Int. J. Radiat. Oncol. Biol. Phys. 14:1988;751-759.
18. Withers H.R. Biological basis of radiation therapy. Perez C.A., Brady L.W. Principles and Practice of Radiation Oncology. 1992;64-96 Lippincott Company, Philadelphia.
19. Wheldon T.E., Deehan C., Wheldon E.G., et al. The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy. Radiat. Oncol. 46:1998;285-295.
20. Gagliardi G., Lax I., Ottolenghi A., Rutqvist L.E. Long-term cardiac mortality after radiotherapy of breast cancer - application of the relative seriality model. Br. J. Radiol. 69:1996;839-846.
21. Gagliardi G. Modeling heart and lung complication data in radiation therapy of the breast. Ph.D Thesis. Department of Medical Radiation Physics. Stockholm University, 1998.
22. Sanchez-Nieto, B.; Nahum, A.E.; Dearnaley, D.P. The customisation of dose prescription based on individual dose-volume and radiosensitivity data. Radiother. Oncol. Submitted.
23. MacKay R.I., Hendry J.H. The modelled benefits of individualising radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability. Radiother. Oncol. 50:1999;67-75.